IMMUNOGENIC POLYPEPTIDES AND USES THEREOF

The present invention relates to new polypeptides, more specifically to immunogenic polypeptides derived from protein Spike of SARS-CoV-2. It also relates to the use of the said polypeptides in eliciting an immune response, preventing or treating a disease caused by the infection by SARS-CoV-2 and d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BLANCO LAVILLA, Esther, RODRÍGUEZ AGUIRRE, Mª Dolores, ALMAZÁN TORAL, Fernando, RODRÍGUEZ FERNÁNDEZ ALBA, Juan Ramón, RODRÍGUEZ AGUIRRE, José Francisco, VARAS RIOS, Antonio Jesús, SANTIAGO HERNÁNDEZ, César Augusto
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to new polypeptides, more specifically to immunogenic polypeptides derived from protein Spike of SARS-CoV-2. It also relates to the use of the said polypeptides in eliciting an immune response, preventing or treating a disease caused by the infection by SARS-CoV-2 and detecting the presence of neutralizing antibodies against SARS-CoV-2. La présente invention concerne de nouveaux polypeptides, plus spécifiquement des polypeptides immunogènes dérivés de protéine de spicule du SARS-CoV-2. L'invention concerne également l'utilisation desdits polypeptides pour déclencher une réponse immunitaire, la prévention ou le traitement d'une maladie provoquée par l'infection par le SARS-CoV-2 et la détection de la présence d'anticorps neutralisants contre le SARS-CoV-2.